IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04109456 |
Recruitment Status :
Recruiting
First Posted : September 30, 2019
Last Update Posted : November 22, 2022
|
Sponsor:
InxMed (Shanghai) Co., Ltd.
Information provided by (Responsible Party):
InxMed (Shanghai) Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | December 30, 2023 |
Estimated Study Completion Date : | June 30, 2024 |